10.08.15
Crown Bioscience has tripled the size of its team in Europe, appointing two new directors of business development, Keith Payne and Jonny McMichael, Ph.D.
Mr. Payne will have responsibility for increasing the number of clients in Israel. He has worked in the pharmaceutical industry in technical and commercial functions for more than 25 years.
Dr. McMichael has more than 15 years of experience in various business development, general management and scientific roles at companies involved in drug discovery and preclinical services. His responsibilities include business development in Scotland, the Cambridge area in the UK, and the Nordic region.
Also, Sebastian Dempe, Ph.D., was recently appointed manager of business development for central Europe; and Severine Marrony, Ph.D., manager of business development in France.
“As the only truly global provider of translational services for oncology and diabetes with support services and facilities in Europe, the Americas and Asia, we continue to respond to our clients’ growing research needs by strengthening our team in Europe and Israel,” said Laurie Heilmann, senior vice president of global strategy, marketing and business development at Crown Bioscience.
Mr. Payne will have responsibility for increasing the number of clients in Israel. He has worked in the pharmaceutical industry in technical and commercial functions for more than 25 years.
Dr. McMichael has more than 15 years of experience in various business development, general management and scientific roles at companies involved in drug discovery and preclinical services. His responsibilities include business development in Scotland, the Cambridge area in the UK, and the Nordic region.
Also, Sebastian Dempe, Ph.D., was recently appointed manager of business development for central Europe; and Severine Marrony, Ph.D., manager of business development in France.
“As the only truly global provider of translational services for oncology and diabetes with support services and facilities in Europe, the Americas and Asia, we continue to respond to our clients’ growing research needs by strengthening our team in Europe and Israel,” said Laurie Heilmann, senior vice president of global strategy, marketing and business development at Crown Bioscience.